Press releasePRNewswire
Evotec SE
EVO · XETRA
$1.50−$0.04 (−2.60%)TodayMarket closed ·
Prev close $1.54
Latest news
- NewsAvi Kapoor
Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday
- Press releasePRNewswire
Evotec Announces Chief Scientific Officer Transition
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
Evotec Subsidiary Just Biologics Moves JST-018 Orthopoxvirus Antibodies Into First-In-Human Phase 1 Study For Biodefense
- Press releasePRNewswire
Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies
- Press releasePRNewswire
Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors
- Press releasePRNewswire
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
- Press releaseBusiness Wire
Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
- Press releaseBusiness Wire
Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management
- NewsAvi Kapoor
Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- NewsAvi Kapoor
Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
- Press releasePRNewswire
Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
- Press releasePRNewswire
Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics
- Press releasePRNewswire
Evotec Reports Results of the Annual General Meeting 2026
- NewsAvi Kapoor
QuickLogic Posts Downbeat Q1 Results, Joins Resideo Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- News
Earnings Scheduled For May 6, 2026
- Press releaseACCESS Newswire
Evotec Receives Grants to Advance Tuberculosis Treatment
- NewsAvi Kapoor
Boyd Gaming Posts Downbeat Q1 Results, Joins Coursera, Evotec And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- News
Correction: Evotec Reported Q4 Earnings On April 8
- News
Earnings Scheduled For April 8, 2026
- News
Evotec Q4 EPS $0.05 Beats $0.02 Estimate, Sales $294.879M Beat $253.350M Estimate
- NewsVandana Singh
Gilead Acquisition Spree Continues With $3 Billion Tubulis Deal
- NewsVandana Singh
Evotec Restructuring Aims To Improve Profitability After Transition Year
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsVandana Singh
Amgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs
- Press releaseACCESS Newswire
Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership
- Press releaseACCESS Newswire
Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution
- News
An Overview of Evotec's Earnings
- Press releaseACCESS Newswire
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
- Press releaseACCESS Newswire
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site
- NewsAvi Kapoor
Nasdaq Surges Over 100 Points; Domino's Shares Fall After Q2 Results
- NewsAvi Kapoor
uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday
- Press releaseACCESSWIRE
Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases
- Press releaseACCESSWIRE
Comment on Withdrawn Non-Binding Offer
- Press releasePRNewswire
Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions
- NewsAvi Kapoor
Intuit Issues Weak Forecast, Joins Reddit And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- Press releasePRNewswire
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
- Press releasePRNewswire
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- NewsVandana Singh
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.